FGF21 Is an Exocrine Pancreas Secretagogue

Cell Metabolism

Volumn 25, Issue 2, 2017, Pages 472-480

  Coate, Katie C ^a   Hernandez, Genaro ^a   Thorne, Curtis A ^a   Sun, Shengyi ^a   Le, Thao D V ^a   Vale, Kevin ^a   Kliewer, Steven A ^a,b   Mangelsdorf, David J ^a,c  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^c HOWARD HUGHES MEDICAL INSTITUTE   (United States)

Author keywords

acinar cell; calcium signaling; CCK; exocrine pancreas; FGF21; pancreatitis; proteostasis; secretagogue; secretion; Klotho

Indexed keywords

AMYLASE; BETA KLOTHO PROTEIN; CALCIUM; CHOLECYSTOKININ; FIBROBLAST GROWTH FACTOR 21; FIBROBLAST GROWTH FACTOR RECEPTOR; FIBROBLAST GROWTH FACTOR RECEPTOR 1; INOSITOL TRISPHOSPHATE; KLOTHO PROTEIN; PHOSPHOLIPASE C; RECOMBINANT FIBROBLAST GROWTH FACTOR; RECOMBINANT FIBROBLAST GROWTH FACTOR 21; TRIACYLGLYCEROL LIPASE; UNCLASSIFIED DRUG; ZYMOGEN GRANULE; FIBROBLAST GROWTH FACTOR; INOSITOL 1,4,5 TRISPHOSPHATE RECEPTOR; PHOSPHOLIPASE C GAMMA;

ACINAR CELL; AMYLASE BLOOD LEVEL; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOCRINE EFFECT; CALCIUM CELL LEVEL; CALCIUM TRANSPORT; CONTROLLED STUDY; ENDOPLASMIC RETICULUM STRESS; ENZYME RELEASE; EXOCRINE PANCREAS; GENE DELETION; MOUSE; NONHUMAN; PARACRINE SIGNALING; POSTPRANDIAL STATE; PRIORITY JOURNAL; PROTEIN HOMEOSTASIS; PROTEIN SYNTHESIS; TRIACYLGLYCEROL LIPASE BLOOD LEVEL; ANIMAL; DIGESTION; ENZYMOLOGY; INTRACELLULAR SPACE; KNOCKOUT MOUSE; MALE; METABOLISM; SIGNAL TRANSDUCTION;

ANIMALS; AUTOCRINE COMMUNICATION; CALCIUM; DIGESTION; ENDOPLASMIC RETICULUM STRESS; FIBROBLAST GROWTH FACTORS; INOSITOL 1,4,5-TRISPHOSPHATE RECEPTORS; INTRACELLULAR SPACE; MALE; MICE, KNOCKOUT; PANCREAS, EXOCRINE; PARACRINE COMMUNICATION; PHOSPHOLIPASE C GAMMA; PROTEIN BIOSYNTHESIS; RECEPTORS, FIBROBLAST GROWTH FACTOR; SIGNAL TRANSDUCTION;

EID: 85009739610     PISSN: 15504131     EISSN: 19327420     Source Type: Journal    
DOI: 10.1016/j.cmet.2016.12.004     Document Type: Article

References (33)

1. Adams, A.C., Coskun, T., Cheng, C.C., O Farrell, L.S., Dubois, S.L., Kharitonenkov, A., Fibroblast growth factor 21 is not required for the antidiabetic actions of the thiazoladinediones. Mol. Metab. 2 (2013), 205–214.
2. Badman, M.K., Pissios, P., Kennedy, A.R., Koukos, G., Flier, J.S., Maratos-Flier, E., Hepatic fibroblast growth factor 21 is regulated by PPARalpha and is a key mediator of hepatic lipid metabolism in ketotic states. Cell Metab. 5 (2007), 426–437.
3. Berna, M.J., Hoffmann, K.M., Tapia, J.A., Thill, M., Pace, A., Mantey, S.A., Jensen, R.T., CCK causes PKD1 activation in pancreatic acini by signaling through PKC-delta and PKC-independent pathways. Biochim. Biophys. Acta 1773 (2007), 483–501.
4. Bookout, A.L., Cummins, C.L., Mangelsdorf, D.J., Pesola, J.M., Kramer, M.F., High-throughput real-time quantitative reverse transcription PCR. Curr. Protoc. Mol. Biol., Chapter 15, 2006 Unit 15 18.
5. Case, R.M., Synthesis, intracellular transport and discharge of exportable proteins in the pancreatic acinar cell and other cells. Biol. Rev. Camb. Philos. Soc. 53 (1978), 211–354.
6. Ding, X., Boney-Montoya, J., Owen, B.M., Bookout, A.L., Coate, K.C., Mangelsdorf, D.J., Kliewer, S.A., βKlotho is required for fibroblast growth factor 21 effects on growth and metabolism. Cell Metab. 16 (2012), 387–393.
7. Eswarakumar, V.P., Lax, I., Schlessinger, J., Cellular signaling by fibroblast growth factor receptors. Cytokine Growth Factor Rev. 16 (2005), 139–149.
8. Fon Tacer, K., Bookout, A.L., Ding, X., Kurosu, H., John, G.B., Wang, L., Goetz, R., Mohammadi, M., Kuro-o, M., Mangelsdorf, D.J., Kliewer, S.A., Research resource: comprehensive expression atlas of the fibroblast growth factor system in adult mouse. Mol. Endocrinol. 24 (2010), 2050–2064.
9. Holmstrom, S.R., Deering, T., Swift, G.H., Poelwijk, F.J., Mangelsdorf, D.J., Kliewer, S.A., MacDonald, R.J., LRH-1 and PTF1-L coregulate an exocrine pancreas-specific transcriptional network for digestive function. Genes Dev. 25 (2011), 1674–1679.
10. Inagaki, T., Dutchak, P., Zhao, G., Ding, X., Gautron, L., Parameswara, V., Li, Y., Goetz, R., Mohammadi, M., Esser, V., et al. Endocrine regulation of the fasting response by PPARalpha-mediated induction of fibroblast growth factor 21. Cell Metab. 5 (2007), 415–425.
11. Ji, B., Song, J., Tsou, L., Bi, Y., Gaiser, S., Mortensen, R., Logsdon, C., Robust acinar cell transgene expression of CreErT via BAC recombineering. Genesis 46 (2008), 390–395.
12. Jiang, S., Yan, C., Fang, Q.C., Shao, M.L., Zhang, Y.L., Liu, Y., Deng, Y.P., Shan, B., Liu, J.Q., Li, H.T., et al. Fibroblast growth factor 21 is regulated by the IRE1α-XBP1 branch of the unfolded protein response and counteracts endoplasmic reticulum stress-induced hepatic steatosis. J. Biol. Chem. 289 (2014), 29751–29765.
13. Johnson, C.L., Weston, J.Y., Chadi, S.A., Fazio, E.N., Huff, M.W., Kharitonenkov, A., Köester, A., Pin, C.L., Fibroblast growth factor 21 reduces the severity of cerulein-induced pancreatitis in mice. Gastroenterology 137 (2009), 1795–1804.
14. Johnson, C.L., Mehmood, R., Laing, S.W., Stepniak, C.V., Kharitonenkov, A., Pin, C.L., Silencing of the fibroblast growth factor 21 gene is an underlying cause of acinar cell injury in mice lacking MIST1. Am. J. Physiol. Endocrinol. Metab. 306 (2014), E916–E928.
15. Kim, S.H., Kim, K.H., Kim, H.K., Kim, M.J., Back, S.H., Konishi, M., Itoh, N., Lee, M.S., Fibroblast growth factor 21 participates in adaptation to endoplasmic reticulum stress and attenuates obesity-induced hepatic metabolic stress. Diabetologia 58 (2015), 809–818.
16. Kubisch, C.H., Logsdon, C.D., Endoplasmic reticulum stress and the pancreatic acinar cell. Expert Rev. Gastroenterol. Hepatol. 2 (2008), 249–260.
17. Kurosu, H., Choi, M., Ogawa, Y., Dickson, A.S., Goetz, R., Eliseenkova, A.V., Mohammadi, M., Rosenblatt, K.P., Kliewer, S.A., Kuro-o, M., Tissue-specific expression of betaKlotho and fibroblast growth factor (FGF) receptor isoforms determines metabolic activity of FGF19 and FGF21. J. Biol. Chem. 282 (2007), 26687–26695.
18. Logsdon, C.D., Ji, B., The role of protein synthesis and digestive enzymes in acinar cell injury. Nat. Rev. Gastroenterol. Hepatol. 10 (2013), 362–370.
19. Markan, K.R., Naber, M.C., Ameka, M.K., Anderegg, M.D., Mangelsdorf, D.J., Kliewer, S.A., Mohammadi, M., Potthoff, M.J., Circulating FGF21 is liver derived and enhances glucose uptake during refeeding and overfeeding. Diabetes 63 (2014), 4057–4063.
20. Mohammadi, M., Honegger, A.M., Rotin, D., Fischer, R., Bellot, F., Li, W., Dionne, C.A., Jaye, M., Rubinstein, M., Schlessinger, J., A tyrosine-phosphorylated carboxy-terminal peptide of the fibroblast growth factor receptor (Flg) is a binding site for the SH2 domain of phospholipase C-gamma 1. Mol. Cell. Biol. 11 (1991), 5068–5078.
21. Ogawa, Y., Kurosu, H., Yamamoto, M., Nandi, A., Rosenblatt, K.P., Goetz, R., Eliseenkova, A.V., Mohammadi, M., Kuro-o, M., BetaKlotho is required for metabolic activity of fibroblast growth factor 21. Proc. Natl. Acad. Sci. USA 104 (2007), 7432–7437.
22. Owen, B.M., Mangelsdorf, D.J., Kliewer, S.A., Tissue-specific actions of the metabolic hormones FGF15/19 and FGF21. Trends Endocrinol. Metab. 26 (2015), 22–29.
23. Potthoff, M.J., Inagaki, T., Satapati, S., Ding, X., He, T., Goetz, R., Mohammadi, M., Finck, B.N., Mangelsdorf, D.J., Kliewer, S.A., Burgess, S.C., FGF21 induces PGC-1alpha and regulates carbohydrate and fatty acid metabolism during the adaptive starvation response. Proc. Natl. Acad. Sci. USA 106 (2009), 10853–10858.
24. Sah, R.P., Garg, S.K., Dixit, A.K., Dudeja, V., Dawra, R.K., Saluja, A.K., Endoplasmic reticulum stress is chronically activated in chronic pancreatitis. J. Biol. Chem. 289 (2014), 27551–27561.
25. Sans, M.D., Lee, S.H., D'Alecy, L.G., Williams, J.A., Feeding activates protein synthesis in mouse pancreas at the translational level without increase in mRNA. Am. J. Physiol. Gastrointest. Liver Physiol. 287 (2004), G667–G675.
26. Schaap, F.G., Kremer, A.E., Lamers, W.H., Jansen, P.L., Gaemers, I.C., Fibroblast growth factor 21 is induced by endoplasmic reticulum stress. Biochimie 95 (2013), 692–699.
27. Singhal, G., Fisher, F.M., Chee, M.J., Tan, T.G., El Ouaamari, A., Adams, A.C., Najarian, R., Kulkarni, R.N., Benoist, C., Flier, J.S., Maratos-Flier, E., Fibroblast growth factor 21 (FGF21) protects against high fat diet induced inflammation and islet hyperplasia in pancreas. PLoS ONE, 11, 2016, e0148252.
28. Wente, W., Efanov, A.M., Brenner, M., Kharitonenkov, A., Köster, A., Sandusky, G.E., Sewing, S., Treinies, I., Zitzer, H., Gromada, J., Fibroblast growth factor-21 improves pancreatic beta-cell function and survival by activation of extracellular signal-regulated kinase 1/2 and Akt signaling pathways. Diabetes 55 (2006), 2470–2478.
29. Williams, J.A., Receptor-mediated signal transduction pathways and the regulation of pancreatic acinar cell function. Curr. Opin. Gastroenterol. 24 (2008), 573–579.
30. Williams, J.A., Blevins, G.T. Jr., Cholecystokinin and regulation of pancreatic acinar cell function. Physiol. Rev. 73 (1993), 701–723.
31. Williams, J.A., Korc, M., Dormer, R.L., Action of secretagogues on a new preparation of functionally intact, isolated pancreatic acini. Am. J. Physiol. 235 (1978), 517–524.
32. Xu, J., Stanislaus, S., Chinookoswong, N., Lau, Y.Y., Hager, T., Patel, J., Ge, H., Weiszmann, J., Lu, S.C., Graham, M., et al. Acute glucose-lowering and insulin-sensitizing action of FGF21 in insulin-resistant mouse models—association with liver and adipose tissue effects. Am. J. Physiol. Endocrinol. Metab. 297 (2009), E1105–E1114.
33. Yang, H., Wang, H., Shivalila, C.S., Cheng, A.W., Shi, L., Jaenisch, R., One-step generation of mice carrying reporter and conditional alleles by CRISPR/Cas-mediated genome engineering. Cell 154 (2013), 1370–1379.